Holdings (as at 2025-06-04)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Elanco Animal Health Incorporated 2.89%
Tenet Healthcare Corporation 2.83%
Insulet Corporation 2.70%
Exelixis, Inc. 2.58%
Cardinal Health, Inc. 2.50%
United Therapeutics Corporation 2.35%
Universal Health Services, Inc. (Class B) 2.23%
Biogen Inc. 2.22%
Doximity, Inc. (Class A) 2.14%
Alnylam Pharmaceuticals, Inc. 2.13%
Premier, Inc. (Class A) 2.12%
Natera, Inc. 2.12%
Penumbra, Inc. 2.10%
The Cigna Group 2.09%
Centene Corporation 2.02%
Molina Healthcare, Inc. 1.99%
HCA Healthcare, Inc. 1.97%
Jazz Pharmaceuticals Plc 1.95%
Hologic, Inc. 1.81%
Abbott Laboratories 1.80%
Viatris Inc. 1.78%
Pfizer Inc. 1.70%
Acadia Healthcare Company, Inc. 1.68%
Amgen Inc. 1.66%
Veeva Systems Inc. (Class A) 1.66%
Vertex Pharmaceuticals Incorporated 1.64%
Encompass Health Corporation 1.60%
DaVita Inc. 1.60%
Intuitive Surgical, Inc. 1.50%
Avantor, Inc. 1.50%
Labcorp Holdings Inc. 1.46%
Zimmer Biomet Holdings, Inc. 1.45%
Royalty Pharma Plc (Class A) 1.43%
Regeneron Pharmaceuticals, Inc. 1.40%
Stryker Corporation 1.37%
Quest Diagnostics Incorporated 1.37%
Henry Schein, Inc. 1.36%
Masimo Corporation 1.30%
Medtronic Plc 1.29%
Eli Lilly and Company 1.27%
Chemed Corporation 1.21%
AbbVie Inc. 1.21%
Organon & Co. 1.20%
Elevance Health Inc. 1.17%
Align Technology, Inc. 1.01%
ResMed Inc. 1.00%
Incyte Corporation 0.99%
Edwards Lifesciences Corporation 0.96%
Steris Plc 0.95%
Agilent Technologies, Inc. 0.90%
West Pharmaceutical Services, Inc. 0.85%
GE HealthCare Technologies Inc. 0.80%
Revvity, Inc. 0.79%
Humana Inc. 0.78%
IQVIA Holdings Inc. 0.77%
UnitedHealth Group Incorporated 0.76%
Thermo Fisher Scientific Inc. 0.74%
The Cooper Companies, Inc. 0.74%
BioMarin Pharmaceutical Inc. 0.73%
Becton, Dickinson and Company 0.67%
DexCom, Inc. 0.53%
IDEXX Laboratories, Inc. 0.52%
Certara, Inc. 0.50%
Neurocrine Biosciences, Inc. 0.48%
Zoetis Inc. 0.44%
Medpace Holdings, Inc. 0.44%
Johnson & Johnson 0.42%
Waters Corporation 0.42%
Charles River Laboratories International, Inc. 0.41%
Solventum Corporation 0.41%
Danaher Corporation 0.40%
Perrigo Company Plc 0.40%
Bruker Corporation 0.39%
Teleflex Incorporated 0.37%
Bio-Techne Corporation 0.36%
Globus Medical, Inc. (Class A) 0.34%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.